About Uni-Pex Pharmaceuticals Private Limited
Data last updated:
Uni-Pex Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1999PTC098759. Its GSTIN is 07AAACU4526E1ZL (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Jagdish Chand Bansal and Madan Lal Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 801 8th Floor Gopal Heights, Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹20.32 Lakh (net margin 4.2%) and EBITDA of ₹44.41 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹6.75 Cr and satisfied charges of ₹20 Cr on record. Court records list 15 cases involving the company, including 4 filed by the company and 11 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unipexpharmaceuticals.com.
Company details
Contact details
Uni-Pex Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is unipexpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address801 8th Floor Gopal Heights, Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uni-Pex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Financials of Uni-Pex Pharmaceuticals Private Limited
FY 2025 filings availableUni-Pex Pharmaceuticals Private Limited reported revenue of ₹4.86 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 18% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹4.86 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Uni-Pex Pharmaceuticals Private Limited
Uni-Pex Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdish Chand Bansal | Director | 10 Mar 1999 | 27 Years 7 Months | Current |
| Madan Lal Bansal | Director | 10 Mar 1999 | 27 Years 7 Months | Current |
Auditor
Uni-Pex Pharmaceuticals Private Limited is audited by AGGARWAL DHEERAJ & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGGARWAL DHEERAJ & ASSOCIATES | FY 2024 | 040522N |
Shareholding
The shareholding of Uni-Pex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2026 | 101234727 | Hdfc Bank Limited | ₹5 Cr | Open | |
| 23 Nov 2021 | 100531614 | Hdfc Bank Limited | ₹1.75 Cr | Open | |
| 14 Sep 2022 | 100621504 | Hdfc Bank Limited | ₹20 Cr | Satisfied |
To see the full charge records of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Uni-Pex Pharmaceuticals Private Limited has 15 court cases on record: 4 filed by Uni-Pex Pharmaceuticals, 11 filed against it. 4 cases are pending and 11 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 8 | 2 |
| District courts | 7 | 3 | 2 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Unique Pharmaceutical Laboratories Ltd. and Anr | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Serum Institute of India Ltd. | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Unique Pharmaceutical Laboratories Ltd. and Anr | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Seagull Pharmaceuticals Pvt. Ltd. | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Unique Pharmaceutical Laboratories Ltd. and Anr | Disposed |
To see the full case history of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Uni-Pex Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 11 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Shivam Enterprises | |||
| Prosperity 6 Pharmaceuticlas | |||
| Mascot Health Series Private Limited. | |||
| Apple Formulations P Ltd |
To see the full MSME payment records of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Uni-Pex Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACU4526E1ZL | Delhi | Active | 01 Jul 2017 |
| 06AAACU4526E1ZN | Haryana | Active | 28 Feb 2023 |
| 06AAACU4526E2ZM | Haryana | Active | 27 Jan 2025 |
To see the full GST registrations and return filing status of Uni-Pex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Uni-Pex Pharmaceuticals Private Limited has 3 board changes on record since 1999: 2 appointments and 1 cessation. The latest: Rajesh Bansal ceased to be Director on 05 Oct 2009.
Frequently asked questions
Uni-Pex Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 1999 (27+ years old) and is registered under CIN U24231DL1999PTC098759.
Uni-Pex Pharmaceuticals has 2 current directors:
- Jagdish Chand Bansal - Director
- Madan Lal Bansal - Director
The latest financial statements of Uni-Pex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Uni-Pex Pharmaceuticals is 07AAACU4526E1ZL, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 06AAACU4526E1ZN (Haryana), 06AAACU4526E2ZM (Haryana).
The CIN (Corporate Identification Number) of Uni-Pex Pharmaceuticals is U24231DL1999PTC098759. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uni-Pex Pharmaceuticals has 15 court cases on record: 4 filed by the company and 11 filed against it. 4 are pending. Most are in the high courts.
Uni-Pex Pharmaceuticals was incorporated on 10 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
Rajesh Bansal ceased to be Director on 05 Oct 2009. Jagdish Chand Bansal was appointed as Director on 10 Mar 1999. Madan Lal Bansal was appointed as Director on 10 Mar 1999.
Uni-Pex Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 11 overdue payments to 7 micro and small suppliers. The latest return was filed on 18 May 2019.
Uni-Pex Pharmaceuticals can be reached through the website unipexpharmaceuticals.com. Its registered office is in Delhi, India.
The registered office of Uni-Pex Pharmaceuticals is at 801 8th Floor Gopal Heights, Netaji Subhash Place Pitampura, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
